SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-051004
Filing Date
2020-04-24
Accepted
2020-04-24 16:20:12
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-2029_3defa14a.htm DEFA14A 32612
2 GRAPHIC g20293bci001.gif GRAPHIC 48032
3 GRAPHIC g20293bci002.gif GRAPHIC 101433
4 GRAPHIC g20293bci003.gif GRAPHIC 21741
5 GRAPHIC g20293bci004.gif GRAPHIC 4184
  Complete submission text file 0001104659-20-051004.txt   275740
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35060 | Film No.: 20815288
SIC: 2834 Pharmaceutical Preparations